Aurinia Resolves Temporary Non-Compliance with Nasdaq’s Audit Committee Composition Rule Jul 12, 2017
Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC Jun 21, 2017
Aurinia Presents Additional Data from Phase Iib Aura-Lv Study, Demonstrating Stable Renal Function and Blood Pressure without Electrolyte Complications Through 48 Weeks Jun 5, 2017
Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences May 30, 2017
Aurinia Doses First Patient in AURORA Phase 3 Clinical Trial of Voclosporin in Lupus Nephritis May 17, 2017
Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of Phase III Aurora Clinical Trial, and Provides Operational Highlights May 15, 2017
